BreatheVision

Remote Respiratory Monitor

Health Tech & Life Sciences
Non Active, May 2026 ceased to operate
Follow

Company Overview

Snapshot

Founded in October 2013 by Ditza Auerbach, BreatheVision operates with 1–10 employees. The company has secured funding across two rounds from PipelBiz and Office of the Chief Scientist, totaling $849K. BreatheVision is recognized for its patent in remote breathing monitoring technology.

Business overview

BreatheVision is an Israeli biotechnology startup specializing in remote respiratory monitoring solutions. The company's core product, SafeSed, is a device designed to accurately measure respiratory volume and patterns without wires or cables. SafeSed aims to provide early alerts for adverse events, helping to prevent respiratory depression and compromise. The company serves the healthcare industry, particularly healthcare providers, and operates within the Health Tech & Life Sciences sector, focusing on medical devices, digital healthcare, and patient remote monitoring.

Strategic signal

In May 2020, BreatheVision's SafeSed device gained attention for its potential to track breath rates, particularly in the context of the coronavirus pandemic. This highlights the company's capability to address critical health monitoring needs with its non-invasive technology, signaling its relevance in rapidly evolving healthcare landscapes and its potential for broader application beyond its initial scope.

Log in to access full profile

Company Intelligence Q&A

Who founded BreatheVision?
BreatheVision was founded by Ditza Auerbach, who also serves as the company's CTO.
When was BreatheVision founded?
BreatheVision was founded in October 2013.
What was a key development for BreatheVision in May 2020?
In May 2020, BreatheVision's SafeSed device was highlighted for its ability to track breath rates, particularly in response to the coronavirus pandemic, demonstrating its potential for critical health monitoring.
What is the current status of BreatheVision?
BreatheVision is currently non-active and ceased to operate in May 2026.
What is BreatheVision's core product?
BreatheVision's core product is SafeSed, a device designed for remote breathing monitoring that accurately measures respiratory volume and patterns without wires or cables.
Log in to access full profile